In Partnership with:
5506 Stories, most recent news story added 8 minutes ago
BioVex , a Woburn, Mass.-based biotechnology company that raised $40 million in venture capital in March to develop a novel cancer-fighting treatment, plans to announce Tuesday that it has raised another $30 million, The Boston Globe reported.
Nov. 9 (Bloomberg) -- Prosecutor Michael Loucks remembers clearly when lawyers for Pfizer Inc., the world’s largest drug company, looked across the table and promised it wouldn’t break the law again.
Title: Istodax Approved for Cutaneous T-Cell Lymphoma Category: Health News Created: 11/6/2009 4:10:00 PM Last Editorial Review: 11/9/2009
And not in the good way.
Miserable in menopause, Elizabeth Alsgaard pondered an awful choice: Drenching hot flashes or hormone therapies that might raise the risk of cancer. What former actress Suzanne Somers raved about held much more appeal -- custom-mixed "bioidentical" hormones, just like ones the body makes.
Maybe you've never seen them, but the demand for "e-cigarettes" is growing fast. Six months ago, vendors report there were roughly 30 U.S. suppliers, a number that's grown to well over 100. But with moves nationwide to regulate their use, it's clear they're lighting up a controversy. CBS 2's Vince Gerasole reports.
Cedars-Sinai patients who were over-exposed to radiation may be at risk for cataracts.
Drug and medical device maker Covidien PLC said Monday it is changing the label on its imaging agent Optimark to show that the product could be dangerous to patients with severe kidney problems.
St. Jude Medical Inc. (STJ), which makes heart-rhythm implants and other complex devices, has withdrawn its membership from the industry's main trade group in a disagreement over the group's approach to managing a government tax proposal.
Washington, DC -- The Food and Drug Administration is warning several companies it says are still selling banned flavored cigarettes to U.S. consumers online.
Orphan drug treatment used only on mice to get hearing before FDA.
Synthetech, Inc. today announced financial results for the second quarter of fiscal 2010, which ended September 30, 2009.
LINCOLNSHIRE, Ill.----BioSante Pharmaceuticals, Inc. today announced that Phillip B. Donenberg, its CFO, will present an overview of the company and its recently completed acquisition of Cell Genesys, as well as give a LibiGel® update at Merriman Curhan Ford’s 6th Annual Investor Summit today, Tuesday November 10, 2009 at the Hotel Sofitel in New York City.
Protections for Gulf Coast Shellfish Industry Would Increase Death Toll WASHINGTON, Nov.
Prosecutor Michael Loucks remembers clearly when lawyers for Pfizer Inc., the world's largest drug company, looked across the table and promised it wouldn't break.
Gulf Coast lawmakers have a message for the administration: Keep your mitts off my raw oysters. Senators from Louisiana and Florida are seething over plans to sanitize -- basically cook -- oyster hauls to fight a potentially deadly bacteria found in the Gulf shellfish. A new Food and Drug Administration rule will ban the sale of fresh, live oysters from the Gulf of Mexico and require they get ...
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters